• KOLs
  • Indolent Lymphoma

Location & Type arrow_drop_up Concepts arrow_drop_down Orgs arrow_drop_down
Filter by Concept
#1
Cancer Biotherapy Research Group
Cancer Biotherapy Research Group
Known for star star star star star
Monoclonal Antibody | Cancer Cells | Autologous Tumor | Chronic Lymphocytic
#2
ROBERT O. DILLMAN
ROBERT O. DILLMAN
Known for star star star star star
Monoclonal Antibody | Autologous Tumor | Indolent Lymphoma | Interferon Alfa

#3
SymBio Pharmaceuticals
SymBio Pharmaceuticals
Known for star star star star star_half
Syb L-0501 | Myelodysplastic Syndrome | Bendamustine Hydrochloride | Relapsed Diffuse
#4
German Low Grade Lymphoma Study Group
German Low Grade Lymphoma Study Group
Known for star star star star star_half
Maintenance Therapy | Follicular Lymphoma | Involved Field | Myeloablative Radio
#5
Martin Hoffmann
Martin Hoffmann
Project Group Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, 93053 Regensburg, Germany
Known for star star star star star_half
Indolent Lymphoma | Budesonide Formoterol | Gemcitabine Oxaliplatin | Severe Chronic
#6
Andres J. M. Ferreri
Andres J. M. Ferreri
Department of Onco-Haematology, Division of Experimental Oncology, IRCCS San Raffaele Hospital, Milan, Italy
Known for star star star star star_half
Induced Thrombocytopenia | Oral Clarithromycin | Intralesional Rituximab | Burkitt Lymphoma
#7
Shandong Lanjin Pharmaceuticals Co.,Ltd
Shandong Lanjin Pharmaceuticals Co.,Ltd
Known for star star star star star_half
Malignant Glioma | Chronic Lymphocytic | Carmustine Sustained | Release Implant
#8
Meng Ji
Meng Ji
The University of Sydney, Sydney, Aust Capital Terr, Australia
Known for star star star star star_half
Indolent Lymphoma | Refractory Diffuse | Chinese Relapsed | Safety Tolerability
#9
Polish Lymphoma Research Group
Polish Lymphoma Research Group
Known for star star star star star_border
Autologous Stem | Allogeneic Hematopoietic | Hodgkin Lymphoma | Molecular Relapse
#10
Jonathan Friedberg
Jonathan Friedberg
The coonsoldated Department of Psychatry, the Neuroscience Program, Harvard Medical School, Boston, Mass, Consolidated Department of Psychiatry, the Neuro‐science ...
Known for star star star star star_border
Indolent Lymphoma | Phase Iii | Free Survival | Evaluate Vitamin
#11
Jan A Walewski
Jan A Walewski
Known for star star star star star_border
Chop Induction | Indolent Lymphoma | Months Chemotherapy | Response Rates
#12
Maria Podolak-Dawidziak
Maria Podolak-Dawidziak
Known for star star star star star_border
Acquired Haemophilia | Chop Induction | Rfviia Concentrate | Indolent Lymphoma
#13
Beata Stella-Hołowiecka
Beata Stella-Hołowiecka
Known for star star star star star_border
Chop Induction | Indolent Lymphoma | Months Chemotherapy | Response Rates
#14
Scientific Foundation
Scientific Foundation
Known for star star star star star_border
Receptor Repertoire | Ocular Indolent | Cancer Immunotherapy | Anti Angiogenesis
#15
Di Deng
Di Deng
Department of Chemistry, Fudan University, Shanghai, 200438, China
Known for star star star star star_border
Follicular Lymphoma | Recurrent Advanced | Field Radiation | Ifrt Response
#16
KaMaH - The Center for Health-Promoting Therapies
KaMaH - The Center for Health-Promoting Therapies
Known for star star star star star_border
Waiting Period | Indolent Lymphoma | Vegan Diet | Intervention Program
#17
Monica Tani
Monica Tani
Hematology Unit, Santa Maria delle Croci Hospital, 48121 Ravenna, Italy;, monica.tani@auslromagna.it
Known for star star star star star_border
Marginal Zone | Loncastuximab Tesirine | Phase Iii | Newly Diagnosed

 

Recently Asked Questions

View all FAQs

Anorexia Nervosa Anorexia nervosa is an eating disorder that is characterized by an intense fear of gaining weight, leading to severe restrictions in food intake and...

 

Mild Stroke A mild stroke, also called a transient ischemic attack (TIA), is a warning sign that a more severe stroke could happen in the future. TIAs are caused by a...

 

Pseudo Tumor A pseudo tumor is a type of growth that can occur in the body. It is not a true tumor, as it is not made up of abnormal cells. However, it can still cause...

 

Functional Constipation Functional constipation is a condition in which bowel movements occur less often than usual or stools are hard to pass. Functional constipation is also...

 

Hypopnea Hypopnea is a disorder characterized by shallow breathing during sleep. The word hypopnea comes from the Greek roots hypo, meaning 'under,' and pnee,...

 

A Randomized Phase Iii Multicenter Trial Assessing Efficacy And Toxicity Of A...

[ CLINICAL_TRIAL ] ... Non-Hodgkin lymphomas (NHL), Follicular Lymphoma (FL) is the second one in terms of frequency, accounting for about 25% of all NHL cases in the western hemisphere. A predominance in ...
Known for star star star star star
Lenalidomide Rituximab | Relapsed Refractory | Indolent Nhl | Months Chop

Ilyad (Indolent Lymphoma And Vitamin D) A Phase Iii Double Blind, Randomized...

[ CLINICAL_TRIAL ] Despite strong evidence suggesting that vitamin D deficiency is associated with undesirable outcomes in patients with numerous cancers, there has never been a thorough study of vitamin D ...
Known for star star star star star_half
Indolent Lymphoma | Phase Iii | Free Survival | Evaluate Vitamin

Rituximab Anti-Cd20 Monoclonal Antibody Plus Oral Cyclophosphamide As Initial...

[ CLINICAL_TRIAL ] ... have indolent stage III or stage IV non-Hodgkin's lymphoma. Detailed Description OBJECTIVES: I. Determine the toxicity associated with cyclophosphamide and rituximab (IDEC-C2B8 monoclonal ...
Known for star star star star star_half
Indolent Lymphoma | Monoclonal Antibody | Oral Cyclophosphamide | Cancer Cells

First-Line R-Cvp Vs R-Chop Induction Immunochemotherapy For Indolent Lymphoma And...

[ CLINICAL_TRIAL ] ... untreated indolent lymphoma patients in need of systemic treatment. Detailed Description Min. 3, max. 8 induction cycles. Maintenance with rituximab q. 2 months x 12/24 months, started 2 ...
Known for star star star star star_half
Chop Induction | Indolent Lymphoma | Months Chemotherapy | Response Rates

A Multicenter, Open Study To Assess The Tolerability, Pharmacokinetics And...

[ CLINICAL_TRIAL ] ... with indolent B-cell Non-Hodgkin's Lymphoma. Detailed Description Indolent B-cell Non-hodgkin's lymphoma is treated mainly with radiation and chemotherapy using a combination of ...
Known for star star star star star_half
Bendamustine Hydrochloride | Indolent Lymphoma | Syb L-0501 | Administered Intravenously

Phase Ib Dose De-Escalation Study Of The Pi3k Alpha/delta Inhibitor, Copanlisib...

[ CLINICAL_TRIAL ] ... zone lymphoma who have received at least one prior line of therapy will receiveCopanlisib IV: day 1, 8, 15 every 28 daysNivolumab IV: Cycle 1 days 1 and 15; then day 1 onlyRituximab IV: ...
Known for star star star star star_half
Immunotherapeutic Agents | Delta Inhibitor | Pi3k Alpha | Refractory Indolent

Rituximab Anti-Cd20 Monoclonal Antibody And Dexamethasone In The Treatment Of...

[ CLINICAL_TRIAL ] ... refractory indolent non-Hodgkin's lymphoma. Detailed Description OBJECTIVES: I. Determine the toxic effects of rituximab and dexamethasone in patients with recurrent or refractory indolent ...
Known for star star star star star_half
Indolent Lymphoma | Monoclonal Antibody | Dexamethasone Rituximab | Tumor Cells

Phase Ii Trial Of Dolastin 10 In Indolent Lymphoma And Chronic Lymphocytic...

[ CLINICAL_TRIAL ] ... with indolent lymphoma, Waldenstrom's macroglobulinemia, or chronic lymphocytic leukemia. Detailed Description OBJECTIVES:Estimate the efficacy of dolastatin 10 in patients with indolent ...
Known for star star star star star_border
Indolent Lymphoma | Lymphocytic Leukemia | Phase Trial | Dolastatin Treating

A Phase Ii, Open-Label Study Of Bortezomib (Velcade), Cladribine And Rituximab...

[ CLINICAL_TRIAL ] RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as cladribine, work in different ways to stop ...
Known for star star star star star_border
Indolent Lymphoma | Bortezomib Cladribine | Cancer Cells | Advanced Mantle

Multicentric Phase I/ii Study For The Efficacy Of A Combination Of Rituximab,...

[ CLINICAL_TRIAL ] ... for indolent lymphoma. In the phase II part the investigators want to estimate the activity of gemcitabine and oxaliplatin in combination with rituximab for patients with ...
Known for star star star star star_border
Indolent Lymphoma | Gemcitabine Oxaliplatin | Phase Combination | Rituximab Relapsed